{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:13:19Z","timestamp":1788336799961,"version":"build-2803163510"},"reference-count":31,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Technology"],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Patients with chronic kidney disease (CKD) undergoing hemodialysis commonly present multiple comorbidities and require complex medication regimens. Polypharmacy increases the risk of clinically relevant drug interactions that may compromise treatment safety and effectiveness.\n                    <jats:bold>Objective:<\/jats:bold>\n                    To estimate the prevalence of potential drug interactions among patients with CKD undergoing hemodialysis and classify these interactions according to clinical risk and mechanism of action.\n                    <jats:bold>Methods:<\/jats:bold>\n                    A cross-sectional study was conducted with patients undergoing hemodialysis at a dialysis clinic in Southern Santa Catarina, Brazil. Potential drug interactions were identified using the Medscape and\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/Drugs.com\">Drugs.com<\/jats:ext-link>\n                    databases and classified according to severity (major, moderate, or minor) and mechanism of action.\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 151 patients were included. Potential drug interactions were identified in all participants (973 interactions; mean 6.4 per patient). Of these, 234 (24.0%) were classified as major, 545 (56.0%) as moderate, and 194 (19.9%) as minor. The most frequent major interactions involved furosemide + losartan (n\u2009=\u20098) and acetylsalicylic acid + clopidogrel (n\u2009=\u20096). Among moderate interactions, the most common were sevelamer + calcium carbonate (n\u2009=\u200914) and losartan + amlodipine (n\u2009=\u200912). The most frequent minor interactions involved epoetin alfa + acetylsalicylic acid (n\u2009=\u200914) and epoetin alfa + calcium carbonate (n\u2009=\u200910). Pharmacodynamic interactions predominated, mainly involving additive effects of cardiovascular medications.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Potential drug interactions were highly prevalent among patients undergoing hemodialysis, with moderate-severity interactions predominating. Routine screening for potential drug interactions may support safer prescribing, optimize pharmacotherapy, and strengthen multidisciplinary medication management in this high-risk population.\n                  <\/jats:p>","DOI":"10.1177\/87551225261471064","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:36:50Z","timestamp":1788169010000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Potential Drug Interactions in Patients With Chronic Kidney Disease Undergoing Hemodialysis"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0948-7279","authenticated-orcid":false,"given":"Maria Let\u00edcia","family":"da Silva Marcelino","sequence":"first","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade, Universidade do Sul de Santa Catarina, Tubar\u00e3o, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4372-1822","authenticated-orcid":false,"given":"Maria Eduarda","family":"Balthazar","sequence":"additional","affiliation":[{"name":"Medical School, Universidade do Sul de Santa Catarina, Tubar\u00e3o, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Zomer Dal Molin","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade, Universidade do Sul de Santa Catarina, Tubar\u00e3o, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Traebert","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade, Universidade do Sul de Santa Catarina, Tubar\u00e3o, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-985X","authenticated-orcid":false,"given":"Jefferson","family":"Traebert","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade, Universidade do Sul de Santa Catarina, Tubar\u00e3o, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisson Jos\u00e9","family":"Trevisol","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade, Universidade do Sul de Santa Catarina, Tubar\u00e3o, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-1594","authenticated-orcid":false,"given":"Fabiana","family":"Schuelter-Trevisol","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade, Universidade do Sul de Santa Catarina, Tubar\u00e3o, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-JBN-2023-0187en"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0103-21002010000400016"},{"key":"e_1_3_2_4_2","unstructured":"Sociedade Brasileira de Nefrologia. Censo Brasileiro de Di\u00e1lise 2024 [Internet]. Sociedade Brasileira de Nefrologia; 2024. Accessed January 5 2026. https:\/\/www.censo-sbn.org.br\/"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.5585\/conssaude.v9i3.2240"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.5902\/2236583440770"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.5935\/0101-2800.20140006"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.55905\/revconv.17n.3-234"},{"key":"e_1_3_2_9_2","unstructured":"Medscape. Medscape Drug Interaction Checker [Internet]. WebMD LLC; 2024. Accessed January 5 2026. https:\/\/reference.medscape.com\/drug-interactionchecker"},{"key":"e_1_3_2_10_2","unstructured":"Drugs.com. Drug Interactions Checker [Internet]. Drugs.com; 2024. Accessed January 5 2026. https:\/\/www.drugs.com\/drug_interactions.html"},{"issue":"10","key":"e_1_3_2_11_2","first-page":"3533","article-title":"Perfil de pacientes com doen\u00e7a renal cr\u00f4nica em hemodi\u00e1lise","volume":"8","author":"Oliveira J\u00fanior RN","year":"2014","unstructured":"Oliveira J\u00fanior RN, Silva GS, Medeiros FA, Fran\u00e7a AKTC, Costa IKF, Torres GV. Perfil de pacientes com doen\u00e7a renal cr\u00f4nica em hemodi\u00e1lise. Rev Enferm UFPE on line. 2014;8(10):3533-3539.","journal-title":"Rev Enferm UFPE on line"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.70032"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.5867\/medwave.2025.02.2915"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-jbn-2021-0210"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.36557\/2674-8169.2024v6n8p-3432-3446"},{"key":"e_1_3_2_16_2","article-title":"Perfil farmacoterap\u00eautico de pacientes renais cr\u00f4nicos hemodial\u00edticos em uma cl\u00ednica da Bahia","volume":"12","author":"Lemos LB","year":"2020","unstructured":"Lemos LB, Moras GS, Lemos GS, Nery AN. Perfil farmacoterap\u00eautico de pacientes renais cr\u00f4nicos hemodial\u00edticos em uma cl\u00ednica da Bahia. J Manag Prim Health Care. 2020;12:e986.","journal-title":"J Manag Prim Health Care"},{"key":"e_1_3_2_17_2","volume-title":"Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas: Anemia na Doen\u00e7a Renal Cr\u00f4nica","author":"Brasil","year":"2021","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas: Anemia na Doen\u00e7a Renal Cr\u00f4nica. Minist\u00e9rio da Sa\u00fade; 2021."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-jbn-2024-0075pt"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-011-0427-z"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.29327\/5660187.2025-12"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.524113"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17239101"},{"key":"e_1_3_2_23_2","volume-title":"Diretrizes Cl\u00ednicas para o Cuidado ao Paciente com Doen\u00e7a Renal Cr\u00f4nica","author":"Sociedade Brasileira de Nefrologia","year":"2022","unstructured":"Sociedade Brasileira de Nefrologia. Diretrizes Cl\u00ednicas para o Cuidado ao Paciente com Doen\u00e7a Renal Cr\u00f4nica. Sociedade Brasileira de Nefrologia; 2022."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-01757-1"},{"issue":"6","key":"e_1_3_2_25_2","first-page":"555","article-title":"Comparison of sevelamer and calcium carbonate in preventing hypomagnesemia in hemodialysis patients","volume":"31","author":"Jandaghi E","year":"2021","unstructured":"Jandaghi E, Yarmohammadi M, Ghorbani R, Jalali T, Salehani AK, Khani PM. Comparison of sevelamer and calcium carbonate in preventing hypomagnesemia in hemodialysis patients. J Ren Nutr. 2021;31(6):555-562.","journal-title":"J Ren Nutr"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2210230"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13244"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000000000315"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.33448\/rsd-v11i2.25488"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019020213"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2010.02299.x"}],"container-title":["Journal of Pharmacy Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/87551225261471064","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/87551225261471064","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/87551225261471064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:19:13Z","timestamp":1788333553000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/87551225261471064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":31,"alternative-id":["10.1177\/87551225261471064"],"URL":"https:\/\/doi.org\/10.1177\/87551225261471064","relation":{},"ISSN":["8755-1225","1549-4810"],"issn-type":[{"value":"8755-1225","type":"print"},{"value":"1549-4810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"87551225261471064"}}